{
    "eid": "2-s2.0-85071779124",
    "title": "Association between hepatitis B surface antigen levels and the risk of hepatocellular carcinoma in patients with chronic hepatitis b infection: Systematic review and meta-analysis",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Chronic hepatitis B infections",
        "Hepatitis B surface antigens",
        "Hepatocellular carcinoma",
        "Meta-analysis"
    ],
    "authors": [
        "Thu Thi Vo",
        "Kittiyod Poovorawan",
        "Pimphen Charoen",
        "Ngamphol Soonthornworasiri",
        "Apichart Nontprasert",
        "Chatporn Kittitrakul",
        "Weerapong Phumratanaprapin",
        "Pisit Tangkijvanich"
    ],
    "citedby-count": 18,
    "ref-count": 25,
    "ref-list": [
        "Prediction of clinical outcomes in Hepatitis B E antigen negative chronic Hepatitis B patients with elevated Hepatitis B virus DNA levels",
        "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level",
        "Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis",
        "Prevention of hepatocellular carcinoma in patients with chronic hepatitis B",
        "Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics",
        "Quantitative levels of Hepatitis B virus DNA and surface antigen and the risk of Hepatocellular Carcinoma in patients with Hepatitis B receiving long-term nucleos(t)ide analogue therapy",
        "Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype",
        "Prediction models of longterm cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles",
        "Serum hepatitis B surface antigen level might predict cirrhosis and hepatocellular carcinoma in older patients with chronic hepatitis B",
        "Serum levels of M2BPGi as short-term predictors of Hepatocellular Carcinoma in untreated Chronic Hepatitis B patients",
        "Serum levels of Hepatitis B surface antigen and DNA can predict inactive carriers with low risk of disease progression",
        "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010",
        "Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients",
        "Effect of serum hepatitis B surface antigen levels on predicting the clinical outcomes of chronic hepatitis B infection: A meta-analysis",
        "Fibrosis-4 index helps identify HBV carriers with the lowest risk of Hepatocellular Carcinoma",
        "High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load",
        "The virological aspects of hepatitis B",
        "Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy",
        "Quadas-2: A revised tool for the quality assessment of diagnostic accuracy studies",
        "Hepatitis B e antigen and the risk of hepatocellular carcinoma",
        "Incorporating serum level of Hepatitis B surface antigen or omitting level of Hepatitis B virus DNA does not affect calculation of risk for Hepatocellular Carcinoma in patients without cirrhosis",
        "Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk",
        "Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Gastroenterology and Hepatology, Singapore General Hospital",
        "Samsung Medical Centre",
        "National Taiwan University Hospital",
        "Faculty of Tropical Medicine, Mahidol University, Thailand Research Fund"
    ]
}